An Ad5-Vectored HIV-1 Vaccine Elicits Cell-mediated Immunity but does not Affect Disease Progression in HIV-1-infected Male Subjects: Results From a Randomized Placebo-Controlled Trial (The Step Study)
Background. The Step study was a randomized trial to determine whether an adenovirus type 5 (Ad5) vector vaccine, which elicits T cell immunity, can lead to control of human immunodeficiency virus (HIV) replication in participants who became HIV-infected after vaccination. Methods. We evaluated the...
Saved in:
Published in | The Journal of infectious diseases Vol. 203; no. 6; pp. 765 - 772 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Oxford
Oxford University Press
15.03.2011
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!